Skip to main navigation

Skip to Content

Overview
Stock Information
News & Events
Financials
- SEC Filings
- Analyst Coverage
Governance
- Governance Highlights
- Committee Composition
Investor Resources

News Releases

2018 Investor Presentation

Year

Nov 09, 2022

HARMONY BIOSCIENCES TO PARTICIPATE IN PIPER SANDLER 34th ANNUAL HEALTHCARE CONFERENCE

Nov 01, 2022

Harmony Biosciences Reports Third Quarter 2022 Financial Results and Business Updates

Nov 01, 2022

HARMONY BIOSCIENCES ANNOUNCES TOPLINE RESULTS FROM PHASE 2 PROOF-OF-CONCEPT STUDY EVALUATING PITOLISANT FOR EXCESSIVE DAYTIME SLEEPINESS IN PATIENTS WITH PRADER-WILLI SYNDROME

Oct 18, 2022

HARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2022 FINANCIAL RESULTS ON NOVEMBER 1, 2022

Sep 22, 2022

HARMONY BIOSCIENCES ANNOUNCES 2022 FUNDING RECIPIENTS OF PATIENTS AT THE HEART AND PROGRESS AT THE HEART AWARD PROGRAMS

Aug 17, 2022

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

Aug 02, 2022

Harmony Biosciences Reports Second Quarter 2022 Financial Results and Business Updates

Jul 19, 2022

HARMONY BIOSCIENCES ANNOUNCES DATE OF SECOND QUARTER 2022 FINANCIAL RESULTS

Jun 06, 2022

HARMONY BIOSCIENCES PRESENTS POST-HOC ANALYSIS OF WAKIX® (PITOLISANT) PIVOTAL DATA IN ADULTS WITH HIGH BURDEN OF NARCOLEPSY SYMPTOMS

May 03, 2022

Harmony Biosciences Reports First Quarter 2022 Financial Results and Business Updates

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 20

Site - Shareholder Tools

Copyright © 2022 Harmony Biosciences All rights reserved.

Facebook
Twitter
LinkedIn
Google+